Table 2 Gonorrhea and chlamydia infection by anatomic sites among 463 MSM in an STI clinic and a community-based clinic in Guangzhou China, 2015–2017
Variables | STI clinic n (frequency) | Community clinic n (frequency) | Total n (frequency) | P* |
|---|---|---|---|---|
Gonorrhea | 34/153(22.2%) | 24/310 (7.7%) | 58/463 (12.5%) | < 0.001 |
Urethral | 22/153 (14.4%) | 2/310 (0.7%) | 24/463 (5.2%) | < 0.001 |
Rectal | 11/153 (7.2%) | 17/310 (5.5%) | 28/463 (6.1%) | 0.469 |
Pharyngeal | 6/153 (3.9%) | 12/310 (3.9%) | 18/463 (3.9%) | 0.979 |
Chlamydia | 29/153 (19.0%) | 55/310(17.7%) | 84/463 (18.1%) | 0.750 |
Urethral | 18/153 (11.8%) | 13/310 (4.2%) | 31/463 (6.7%) | 0.002 |
Rectal | 10/153 (6.5%) | 42/310 (13.6%) | 52/463 (11.2%) | 0.025 |
Pharyngeal | 1/153 (0.7%) | 5/310 (1.6%) | 6/463 (1.3%) | 0.391 |
HIV | 20/153 (13.1%) | 40/310 (12.9%) | 60/463 (13.0%) | 0.959 |
aOther STIs | 49/153 (32.0%) | 35/310 (11.3%) | 84/463 (18.1%) | < 0.001 |